ПРОДУКТ
Iron saccharate
| Chemical Name | : Iron saccharate |
| Category | : |
| Specification | : |
| HS Code | : 29400000.00 |
- Телефон: +86-532-83876123
- Факс: +86-532-83876157
- Email: dennis@qingmeibio.com
- Skype: dennis10221
ХИМИЧЕСКАЯ ХАРАКТЕРИСТИКА
| Structure Formula | :  |
| CAS Number | : 8047-67-4 |
| Molecular Formula | : C18H24Fe2O24 |
| Usage | : Heparin is extracted from porcine intestinal mucosa of mucopolysaccharides biochemical medicine has strong anticoagulation activity. Mclcan in the study of coagulation mechanism from dog liver tissue was identified in the shares of mucopolysaccharide substance heparin. Brinkous has proved that heparin anticoagulant activity, after the first clinical application of heparin as anticoagulant, have attracted the attention of the world, heparin has anticoagulant effect strong, prevention and treatment of deep vein thrombosis drug of choice for thrombus disease, clinical although there are more than 60 years of history, but so far there is no can completely replace the products, so it is still the most important anti coagulation and anti thrombosis of biochemical drugs. A wide range of uses in medicine for the treatment of disease, acute myocardial infarction, primality hepatitis, combined with ribonucleic acid can increase the efficacy of hepatitis B, combined with chemotherapy, is conducive to the prevention of thrombosis, also have a role in lowering blood lipid and improve human immune function. Low molecular weight heparin has anti factor Xa activity, pharmacodynamics study showed that low molecular weight heparin sodium has inhibitory effect on the formation of thrombosis in vivo,, arteriovenous thrombosis, and on blood coagulation and fibrinolysis system produced little influence, antithrombotic effect, bleeding possibility small. Unfractionated heparin is a mixture containing a variety of amino dextran glucoside, can slow or stop blood coagulation in vivo. The anticoagulant mechanism is complex, the role of various aspects of coagulation. Including the inhibition of prothrombin into thrombin; thrombin inhibition activity; hinder the conversion of fibrinogen to fibrin platelet aggregation and destruction; prevent. Heparin can reduce blood fat, decrease LDL and VLDL, increased HDL, the changes of blood viscosity, the protection of vascular endothelial cells, prevent atherosclerosis, the role of promoting blood flow, improve the coronary circulation etc.. |
ТЕХНИЧЕСКИЙ ПАРАМЕТР
| Items | Standard |
|---|---|
| Appearance | |
| Solubility | |
| Identification | |
| Appearance of solution | |
| Related substances | |
| Impurity B | ≤ppm |
| Impurity P | ≤0.0% |
| Impurity C | ≤0.0% |
| Impurity N | ≤0.0% |
| Impurity O | ≤0.0% |
| Impurity I | ≤0.0% |
| Impurity J | ≤0.0% |
| Impurity F | ≤0.% |
| Impurity A | ≤0.0% |
| Impurity K | ≤0.0% |
| Impurity G | ≤0.0% |
| Any other impurity | ≤0.0% |
| Total impurities | ≤0.% |
| Water | ≤% |
| Sulphated Ash | ≤0.% |
| Residual Solvent | |
| Toluene | ≤ppm |
| Assay (anhydrous basis，content of Cefadroxil) | % |
ЗАРЕГИСТРИРОВАННЫЕ ДОКУМЕНТЫ
The available documents are:
Chinese GMP
CEP
DMF/CTD format
The available registered countries are:
Algeria
Spain
Australia
Chinese GMP
CEP
DMF/CTD format
The available registered countries are:
Algeria
Spain
Australia